Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Denise E. Morris
Observed names:
Denise E Morris,
Denise Morris,
Morris, Denise,
Morris, Denise E,
Morris, Denise E.,
Morris, Denise Elizabeth
show all 6
Institutions:
Drug Safety Research Unit,
University of Southampton,
University of Portsmouth
Observed institutions:
University Hospital Southampton NHS Foundation Trust,
Drug Safety Research Unit,
University of Southampton,
University of Portsmouth
ORCID:
0000-0002-8920-0812
Observed ORCID:
0000-0002-8920-0812
OpenAlex ID:
A5047931092
Secondary Bacterial Infections Associated with Influenza Pandemics
2017
·
Denise E. Morris
, David W. Cleary
, et al.
·
Frontiers in Microbiology
·
592
PDF
The rise and fall of pneumococcal serotypes carried in the PCV era
2017
·
Vanessa T. Devine
, David W. Cleary
, et al.
·
Vaccine
·
75
The upper respiratory tract microbiome of indigenous Orang Asli in north-eastern Peninsular Malaysia
2021
·
David W. Cleary
, Denise E. Morris
, et al.
·
npj Biofilms and Microbiomes
·
41
PDF
Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae
2018
·
David Cleary
, Vanessa Devine
, et al.
·
Microbial Genomics
·
24
The characterization of Moraxella catarrhalis carried in the general population
2022
·
Denise E. Morris
, Karen L. Osman
, et al.
·
Microbial Genomics
·
21
Carriage of upper respiratory tract pathogens in rural communities of Sarawak, Malaysian Borneo
2021
·
on behalf of the MYCarriage group
, Denise E. Morris
, et al.
·
Pneumonia
·
15
PDF
Vaccination in Southeast Asia—Reducing meningitis, sepsis and pneumonia with new and existing vaccines
2014
·
Alice Richardson
, Denise E. Morris
, et al.
·
Vaccine
·
10
Ecology and diversity in upper respiratory tract microbial population structures from a cross-sectional community swabbing study
2018
·
Abigail L. Coughtrie
, Denise E. Morris
, et al.
·
Journal of Medical Microbiology
·
7
Changes in carriage and serotype diversity of Streptococcus pneumoniae and other respiratory pathobionts in the UK between pre-PCV13 (2006-10), early-PCV13 (2010-12) and late-PCV13 (2012-23) periods
2025
·
David W. Cleary
, Rebecca Anderson
, et al.
·
Pneumonia
·
5
PDF
Respiratory carriage of hypervirulent Klebsiella pneumoniae by indigenous populations of Malaysia
2024
·
Souradeep Das
, Anish K. Pandey
, et al.
·
BMC Genomics
·
5
PDF
Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study
2025
·
Alison Evans
, Debabrata Roy
, et al.
·
BMJ Open
·
4
A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements
2026
·
Dawn Cooper
, Mohammed Toseef Ansari
, et al.
·
Drug Safety
·
2
Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study
2026
·
Joan Forns
, Romin Pajouheshnia
, et al.
·
Vaccine
·
1
The Road Less Traveled: Exploring the Genomic Characteristics and Antimicrobial Resistance Potential of Acinetobacter baumannii From the Indigenous Orang Asli Community in Peninsular Malaysia
2025
·
Soo‐Sum Lean
, Denise E. Morris
, et al.
·
MicrobiologyOpen
·
1
Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources
2025
·
Laura C. Zwiers
, Diederick E. Grobbee
, et al.
·
Vaccines
·
1
PDF
Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeablehaemophilus influenzae
2015
·
Karl J. Staples
, Zoe Pounce
, et al.
·
European Respiratory Journal
·
1
TARGET-EU: Effectiveness of BNT162b2 mRNA COVID-19 vaccine in healthy individuals or with stable pre-existing medical conditions against SARS-CoV-2 infection
2026
·
Andaur Navarro, Constanza L.
, Mohammadi, Sima
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
TARGET-EU: Dapagliflozin and major adverse cardiovascular events in type 2 diabetes
2026
·
Lasys, Tomas
, Mohammadi, Sima
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
TARGET-EU: Comparison of single-device vilanterol/fluticasone furoate with other single-device inhaled corticosteroid and long-acting beta agonist combinations in the risk of pneumonia in adolescents with asthma
2026
·
Lasys, Tomas
, Mohammadi, Sima
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
TARGET-EU: The risk of angiooedema and other safety events in heart failure patients treated with sacubitril/valsartan compared to angiotensin-converting enzyme inhibitors
2026
·
Lasys, Tomas
, Mohammadi, Sima
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Enhanced passive safety surveillance (EPSS) of a seasonal intranasal influenza vaccine (Fluenz® Tetra) in children in England: methodology, results and lessons learned from eight influenza seasons (2015/2016 to 2022/2023)
2026
·
Sandeep Dhanda
, Denise E Morris
, et al.
·
Vaccine
PDF
DrugSet: A validated R Shiny application for reproducible drug codelist construction from ATC classification to CPRD Aurum prodcodes
2026
·
Vjola Hoxhaj
, Catherine Fry
, et al.
·
medRxiv
PDF
TARGET-EU: Tolvaptan and risk associated to hepatotoxicity in autosomal dominant polycystic kidney disease
2026
·
Lasys, Tomas
, Mohammadi, Sima
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Carriage epidemiology of Moraxella catarrhalis in an all-age community cohort between 2016 and 2018
2026
·
Denise E. Morris
, Alex J. J. Lister
, et al.
·
Access Microbiology
Corrigendum: Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae
2021
·
David W. Cleary
, Vanessa T. Devine
, et al.
·
Microbial Genomics
Show more works
View as search
Works count:
33
Citation count:
805
H-index:
7
I10-index:
7
Year
Topic
Type
